Lv3
305 积分 2021-08-30 加入
Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
2个月前
已完结
MNK: A Novel Promising Target for Cancer Immunotherapy
3个月前
已完结
Next-generation CAR-T cells design: leveraging tumor features for enhanced efficacy
3个月前
已完结
Cytokine control of memory T-cell development and survival
6个月前
已完结
Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence
7个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
7个月前
已完结
Advancing CAR T-cell Therapies with Artificial Intelligence: Opportunities and Challenges
8个月前
已完结
Mesothelin-Specific CAR T Cells Target Ovarian Cancer
8个月前
已完结
A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape
8个月前
已完结
Abstract 3173: JL-lightning CAR-T, a next generation non-viral CAR-T without in-vitro culturing procedure, shows high clinical efficacy, good safety with low treatment dosage
8个月前
已关闭
皖公网安备34019202002308
